Home > Boards > US Listed > Medical - Drugs > Opiant Pharmaceuticals Inc. (OPNT)

Can't understand why we're not getting any attention.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
catty Member Profile
 
Followed By 39
Posts 8,240
Boards Moderated 0
Alias Born 06/23/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/23/2021 4:06:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 4:15:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/15/2021 4:02:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/14/2021 4:02:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/13/2021 4:08:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2021 4:03:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2021 4:05:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/25/2021 4:39:19 PM
Opiant Pharmaceuticals to Participate in September Investor Conferences GlobeNewswire Inc. - 8/25/2021 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/24/2021 6:04:34 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2021 4:05:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/16/2021 4:48:40 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/13/2021 4:33:56 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 4:18:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 4:11:36 PM
Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 8/5/2021 4:01:00 PM
Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 GlobeNewswire Inc. - 7/22/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/20/2021 4:11:16 PM
Opiant Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 7/20/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2021 4:06:36 PM
Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer GlobeNewswire Inc. - 7/12/2021 8:00:00 AM
Opiant shares soar 35% on OPNT003 opioid overdose study results Seeking Alpha - 7/6/2021 4:05:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 4:04:47 PM
Opiant Pharmaceuticals Announces Positive Top-line Results of Confirmatory Pharmacokinetic (PK) Study for OPNT003, Nasal Nalm... GlobeNewswire Inc. - 7/6/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 4:08:36 PM
catty   Sunday, 10/13/19 11:22:21 AM
Re: None
Post # of 1506 
Can't understand why we're not getting any attention. Any thoughts??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences